跳至主要内容
临床试验/IRCT2013040712933N1
IRCT2013040712933N1已完成3 期

The effect of Berberis root active component (Berberine) on blood sugar control in patients with Type2 Diabetes.

Vice chancellor for research Ahvaz University of Medical Sciences0 个研究点目标入组 84 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
已完成
发起方
入组人数
84

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
30 years 至 65 years(—)
性别
All

入选标准

  • Age 30-65 years; HbA1C 7-8.5; Fasting Blood Sugar 126 -200; diagnosis of Diabetes less than 10 years; Only use oral blood glucose lowering drugs .
  • Exclusion critria: Fasting Blood Sugar More Than 200; HbA1C More Than 8.5 ;triglyceride More Than 500; pregnancy; Consumers of anticoagulants drugs
  • (except Aspirin); chronic liver disease except fatty liver disease; proliferative Diabetic retinopathy; Renal Failure; Heart failure; Hemorrhagic strokes; hypothyroidism and hyperthyroidism; treatment with Insulin.

排除标准

  • 未提供

研究者

发起方
Vice chancellor for research Ahvaz University of Medical Sciences

相似试验